Earning a failing grade : a report card on 1992 drug manufacturer price inflation : staff report to the Special Committee on Aging, United States Senate.

A Status report : accessibility and affordability of prescription drugs for older Americans (annotated) : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate.
Published: (1992)

Medicare Part D : Drug Pricing and Manufacturer Windfalls.
Published: (2008)

Pricing of drugs, 1977 : joint hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources and the Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary, United States Senate, 95th Congress, first session ... July 14, 1977.
Published: (1977)

Pay-for-delay : how drug company pay-offs cost consumers billions : an FTC staff study.
Published: (2010)

Entry threats and pricing in the generic drug industry /
by: Wendling, Brett
Published: (2010)

Drug pricing investigation: lost savings : how prohibiting Medicare negotiation has cost taxpayers : staff report /
Published: (2021)

Reasonable Rx : solving the drug price crisis /
by: Finkelstein, Stan N.
Published: (2008)

Prescription drug advertising to consumers : staff report /
Published: (1984)

Pricing a new drug /
by: Munshaw, Supriya, et al.
Published: (2019)

Drug topics red book.
Published: (1992)

Pharmacy benefit managers : early results on ventures with drug manufacturers : report to the Honorable Ron Wyden, House of Representatives /
Published: (1995)

The Drug manufacturing industry : a prescription for profits : staff report of the Special Committee on Aging, United States Senate.
Published: (1991)

Making medicine, making money /
by: Drake, Donald, 1935-
Published: (1993)

Drug pricing investigation: industry spending on buybacks, dividends, and executive compensation : staff report /
Published: (2021)

Studies in pharmaceutical economics /
Published: (1996)

The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1993.
Published: (1993)

Drug product selection : staff report to the Federal Trade Commission.
Published: (1979)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

Competition in prescription drug markets, 2017-2022 /
by: Parasrampuria, Sonal, et al.
Published: (2023)

Economic analysis of the causes of drug shortages.
Published: (2011)

Prescription Drug Pricing in the Private Sector : CBO Paper.
Published: (2007)

Drug shortages : why they happen and what they mean : hearing before the Committee on Finance, United States Senate, One Hundred Twelfth Congress, first session, December 7, 2011.
Published: (2011)

Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993.
Published: (1993)

Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session.
Published: (2019)

Red book.
Published: (2004)

Resistant prices : a study of competitive strains in the antibiotic markets /
by: Brooke, Paul A.
Published: (1975)

The role of pharmacy benefit managers in prescription drug markets : report prepared by the House Committee on Oversight and Accountability staff.
Published: (2024)

Drug shortages, public health threat continues, despite efforts to help ensure product availability : report to congressional addressees.
Published: (2014)

Pharmaceutical marketplace reform : is competition the right prescription? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, November 16, 1993.
Published: (1994)

Drug topics red book.
Published: (1995)

Drug shortage crisis : lives are in the balance : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, November 30, 2011.
Published: (2012)

Unsustainable drug prices : hearing before the Committee on Oversight and Reform, House of Representatives.
Published: (2020)

Creating and Restoring Equal Access to Equivalent Samples Act of 2019 : report (to accompany H.R. 965) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007.
Published: (2007)

Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007.
Published: (2007)